|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/06 | |
| A61K 31/4709 |
| (11) | Patento numeris | 2697215 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12706221.4 |
| Europos patento paraiškos padavimo data | 2012-02-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/052504 |
| Data | 2012-02-14 |
| (87) | Numeris | WO 2012/119841 |
| Data | 2012-09-13 |
| (30) | Numeris | Data | Šalis |
| 201103837 | 2011-03-07 | GB |
| (72) |
BETANCOURT, Aimesther, CA
LEMIEUX, Marc, CA
THIBERT, Roch, CA
|
| (73) |
Atopix Therapeutics Limited,
265 Strand, London WC2R 1BH,
GB
|
| (54) | AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |
| AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYL-INDOL-1-YL)-ACETIC ACID |